Green Chemistry - Environmentally Benign Approaches 2012
DOI: 10.5772/36489
|View full text |Cite
|
Sign up to set email alerts
|

Green Chemistry – Aspects for the Knoevenagel Reaction

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
9
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 55 publications
0
9
0
Order By: Relevance
“…Another reaction, the Knoevenagel condensation, involves benzaldehyde and malonic acid in the presence of a weak base ( e.g . pyridine), with subsequent acid hydrolysis . An exemplary modification of this method uses pyridine as a solvent and a catalyst, and β ‐alanine as a co‐catalyst .…”
Section: Introductionmentioning
confidence: 99%
“…Another reaction, the Knoevenagel condensation, involves benzaldehyde and malonic acid in the presence of a weak base ( e.g . pyridine), with subsequent acid hydrolysis . An exemplary modification of this method uses pyridine as a solvent and a catalyst, and β ‐alanine as a co‐catalyst .…”
Section: Introductionmentioning
confidence: 99%
“…Because of its operational simplicity and expedited access to α,β-unsaturated motifs, the Knoevenagel condensation has found multiple applications in organic synthesis, including in industrial settings . One of its key features is the possibility to engage the resulting alkene in tandem processes, such as Michael, Diels–Alder, or sigmatropic reactions .…”
Section: Introductionmentioning
confidence: 99%
“…[30][31][32][33][34][35][36][37][38][39][40][41] Natural products like ajmalicine (1, antihypertensive alkaloid) and pharmaceuticals like AMG 837 (2, type II diabetes) and clinical agents such as atorvastatin (3, cardiovascular disease), lumefantrine (4, malaria) and sunitinib (5, gastrointestinal stromal tumor) are the representatives prepared by utilising Knoevenagel reaction (Figure 1). [17,[42][43][44] Dr. Ramya Tokala was born in Vijayawada, Andhra Pradesh, India, in 1991. The synthesis of these clinical agents emphasising the Knoevenagel reaction isis outlined in Scheme 3.…”
Section: Pharmaceutical Significance Of the Knoevenagel Reactionmentioning
confidence: 99%